Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Lable Randomised Two -Arm Study to Assess the Safety and Efficacy of Paromomycin Administered Intramuscularly at Two Different Dosing Regimens (14 Days Versus 21 Days) for the Treatment of Indian Visceral Leishmaniasis (VL)

NCT00629031 is registered in ClinicalTrials.gov with Banaras Hindu University as lead sponsor.

NCT NCT00629031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00629031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Lable Randomised Two -Arm Study to Assess the Safety and Efficacy of Paromomycin Administered Intramuscularly at Two Different Dosing Regimens (14 Days Versus 21 Days) for the Treatment of Indian Visceral Leishmaniasis (VL)
Lead sponsor
Banaras Hindu University
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2008
Completion date
August 31, 2008
Enrollment
329 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

visceral leishmaniasis